CA2322850A1 - Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance - Google Patents

Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance Download PDF

Info

Publication number
CA2322850A1
CA2322850A1 CA002322850A CA2322850A CA2322850A1 CA 2322850 A1 CA2322850 A1 CA 2322850A1 CA 002322850 A CA002322850 A CA 002322850A CA 2322850 A CA2322850 A CA 2322850A CA 2322850 A1 CA2322850 A1 CA 2322850A1
Authority
CA
Canada
Prior art keywords
cream
oil
weight
emulsifier
galactolipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002322850A
Other languages
English (en)
French (fr)
Inventor
Anders Carlsson
Jenny Ek
Bengt Herslof
Goran Nilsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIPOCORE HOLDING AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20410443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2322850(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2322850A1 publication Critical patent/CA2322850A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002322850A 1998-03-06 1999-03-08 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance Abandoned CA2322850A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9800729-7 1998-03-06
SE9800729A SE9800729L (sv) 1998-03-06 1998-03-06 Ny topikal formulering I
PCT/SE1999/000347 WO1999044585A1 (en) 1998-03-06 1999-03-08 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance

Publications (1)

Publication Number Publication Date
CA2322850A1 true CA2322850A1 (en) 1999-09-10

Family

ID=20410443

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002322850A Abandoned CA2322850A1 (en) 1998-03-06 1999-03-08 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance

Country Status (12)

Country Link
EP (1) EP1069886B1 (https=)
JP (1) JP2002505272A (https=)
AT (1) ATE253895T1 (https=)
AU (1) AU750526B2 (https=)
CA (1) CA2322850A1 (https=)
DE (1) DE69912760T2 (https=)
DK (1) DK1069886T3 (https=)
ES (1) ES2211062T3 (https=)
NZ (1) NZ506756A (https=)
PT (1) PT1069886E (https=)
SE (1) SE9800729L (https=)
WO (1) WO1999044585A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2304906A1 (en) 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
EP1151745A1 (fr) * 2000-05-05 2001-11-07 L'oreal Composition sous forme d'émulsion eau-dans-huile et ses utilisations cosmétiques
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
AU2003279622A1 (en) 2002-06-28 2004-01-19 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
KR101243526B1 (ko) * 2004-08-31 2013-03-20 스티펠 리서치 오스트레일리아 피티와이 리미티드 마이크로에멀젼 및 서브마이크론 에멀젼 방법 및 조성물
US8449867B2 (en) 2004-08-31 2013-05-28 Stiefel Research Australia Pty Ltd Microemulsion and sub-micron emulsion process and compositions
PL1879466T5 (pl) * 2005-03-04 2016-07-29 Dsm Ip Assets Bv Spożywcza cząsteczkowa kompozycja lipidowa
DE102005023640A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure
US20080260816A1 (en) * 2005-09-16 2008-10-23 Bengt Herslof Particulate Lipid Pharmaceutical Composition
EP2455382B1 (en) 2005-12-13 2016-10-26 Incyte Holdings Corporation Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
WO2008084253A1 (en) * 2007-01-12 2008-07-17 Lipopeptide Ab Use of a galactolipid for wound and ulcer healing
US20100136124A1 (en) * 2007-04-20 2010-06-03 University Of South Australia Nanoparticle-coated capsule formulation for dermal drug delivery
PT2496263T (pt) 2009-11-03 2022-03-28 Lipidor Ab Composição que forma uma camada lipídica para administração sobre uma superfície de um organismo vivo
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
SG10201801069QA (en) 2013-08-07 2018-03-28 Incyte Corp Sustained release dosage forms for a jak1 inhibitor
JP2017529334A (ja) * 2014-08-27 2017-10-05 アッヴィ・インコーポレイテッド 局所製剤
US11617724B2 (en) 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
CN107666902B (zh) 2015-05-21 2021-09-21 德玛万科学有限责任公司 局部药物组合物
CN108282998B (zh) 2015-06-18 2021-07-06 凡利亚药品北美公司 用于治疗银屑病的包含皮质类固醇和类视黄醇的局部组合物
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597118A (ja) * 1982-06-16 1984-01-14 ユニリ−バ−・ナ−ムロ−ゼ・ベンノ−トシヤ−プ 化粧用組成物
JPS649908A (en) * 1987-07-02 1989-01-13 Kao Corp Cosmetic, cosmetic set and make-up method
JPH0374316A (ja) * 1989-08-11 1991-03-28 Kanebo Ltd 保湿剤
JPH0818948B2 (ja) * 1990-08-31 1996-02-28 花王株式会社 水性化粧料及びその製造法
JPH0543465A (ja) * 1991-08-08 1993-02-23 Mitsubishi Kasei Corp コルチコステロイド含有ローシヨン剤
JPH069365A (ja) * 1992-06-25 1994-01-18 Kanebo Ltd 皮膚化粧料
PL176941B1 (pl) * 1993-03-12 1999-08-31 Axys Pharmaceuticals Nowe peptydy i środek farmaceutyczny do leczenia immunologicznych stanów zapalnych
FR2710854B1 (fr) * 1993-10-08 1995-12-01 Oreal Emulsion huile-dans-eau utilisable pour l'obtention d'une crème.
BR9506681A (pt) * 1994-02-04 1997-11-18 Scotia Lipidteknik Ab Emulsão oleo em água e composição farmacêutica
SE9402453D0 (sv) * 1994-07-12 1994-07-12 Astra Ab New pharmaceutical preparation
JPH08165244A (ja) * 1994-10-12 1996-06-25 Taisho Pharmaceut Co Ltd 皮膚疾患治療剤
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
SE504664C2 (sv) * 1995-09-22 1997-03-24 Scotia Lipidteknik Ab Sätt att framställa fraktionerad olja, oljan, dess användning samt emulsionskomposition innehållande oljan
JP3326059B2 (ja) * 1995-10-05 2002-09-17 カネボウ株式会社 皮膚化粧料

Also Published As

Publication number Publication date
JP2002505272A (ja) 2002-02-19
ES2211062T3 (es) 2004-07-01
WO1999044585A1 (en) 1999-09-10
AU750526B2 (en) 2002-07-18
EP1069886A1 (en) 2001-01-24
DE69912760D1 (de) 2003-12-18
SE9800729D0 (sv) 1998-03-06
DE69912760T2 (de) 2004-09-30
PT1069886E (pt) 2004-04-30
EP1069886B1 (en) 2003-11-12
SE9800729L (sv) 1999-09-07
ATE253895T1 (de) 2003-11-15
DK1069886T3 (da) 2004-03-22
NZ506756A (en) 2003-10-31
AU3177899A (en) 1999-09-20

Similar Documents

Publication Publication Date Title
EP1069886B1 (en) Use of a topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, for providing a prolonged effect of an incorporated active substance
US5945409A (en) Topical moisturizing composition and method
US6911211B2 (en) Pharmaceutical and cosmetic carrier or composition for topical application
US5851543A (en) Skin care preparation and method
CN108024954A (zh) 局部用类视黄醇组合物
US12144884B2 (en) Skin barrier protective delivery systems
US20050063930A1 (en) Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance
US20020012648A1 (en) High phospholipid-containing dermatological compositions
AU745463B2 (en) Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect
NZ250463A (en) Lanolin containing compositions; skin treatment compositions containing lanolin, lanolin acid ester and lanolin oil
US20070225234A1 (en) Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect
CN105796461A (zh) 含水解珍珠粉柔性纳米脂质体和沙棘油的保湿修复乳
US20050244359A1 (en) Topical regulation of triglyceride metabolism
EP3352724B1 (en) Hydrophobic gel based on vitamin e free from silicone products for topical application
RU2836338C1 (ru) Косметический крем для ухода за сухой кожей
WO2023205499A1 (en) Skin barrier protective delivery systems and methods thereof
EP3372221B1 (en) Hydrophobic gel based on vitamin e free from silicone products for topical application
WO2023101546A1 (en) Cream for protection and strengthening of the epidermal lipid barrier of the hand skin, when the skin is frequently exposed to disinfectants
Harris et al. 25 Lanolins

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20060308